Enthea
United States
- Boston
- 19/12/2022
- Seed
- $2,000,000
Psychedelic Healthcare as a Workplace Benefit.
Creating benefit plans for progressive, compassionate employers.
We are on a mission to expedite safe, affordable access to psychedelic-assisted therapy for all who can benefit.
Supporting healing from within.
- Industry Insurance and Employee Benefit Funds
- Website https://www.enthea.com/
- LinkedIn https://www.linkedin.com/company/entheahealth/
Related People
Sherry R.Founder
Canada -
Toronto, Ontario
I have helped dozens of startups, non-profit organizations, academic/research institutions, and small businesses raise funds, operate according to their mission and values, and implement processes that enhance their efficiency.
I believe in living and working in alignment with purpose and I am currently focused on expanding access to psychedelic-assisted therapy to alleviate human suffering.
Before this, I consulted with the United Nations and World Bank for 10 years, implementing cash transfer programs at the national level in over 35 countries.
I have a Master’s Degree in Public Policy and Management from the London School of Economics and a Bachelor’s Degree in Neuroscience and International Development from McGill University. I also completed the Certificate in Psychedelic Therapies and Research from CIIS in 2021.
In addition to being Enthea's CEO, I am the Executive Director of the Boston Psychedelic Research Group, HR Consultant for Sensorium Therapeutics, and Strategic Advisor for CIIS.
Dark Watch | $3,500,000 | (Mar 17, 2026)
Alomana | $4,597,680 | (Mar 17, 2026)
Gangkhar | $4,250,000 | (Mar 17, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
Great Sky | $14,000,000 | (Mar 17, 2026)
Understood Care | $5,000,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)
Certiv | $4,200,000 | (Mar 17, 2026)
Scanner | $22,000,000 | (Mar 17, 2026)
Zero RFI | $13,800,000 | (Mar 17, 2026)
Nadia Care | $12,000,000 | (Mar 17, 2026)
Eileen Inc. | $1,000,000 | (Mar 17, 2026)
Halcyon(US) | $21,000,000 | (Mar 17, 2026)